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1 
 Colorectal adenomas are known as precursors for the majority of colorectal 2 
carcinomas. While weight gain during adulthood has been identified as a risk factor for 3 
colorectal cancer, the association is less clear for colorectal adenomas. We conducted a 4 
systematic review and metaanalysis to quantify the evidence on this association.  5 
: We searched MEDLINE up to September 2016 to identify observational (prospective, 6 
crosssectional and retrospective) studies on weight gain during adulthood and colorectal 7 
adenoma occurrence and recurrence. We conducted metaanalysis on high weight gain versus 8 
stable weight, linear and nonlinear doseresponse metaanalyses to analyze the association. 9 
Summary odds ratios (OR) and 95% confidence intervals (95% CI) were estimated using a 10 
random effects model. 11 
 For colorectal adenoma occurrence, the summary OR was 1.39 (95% CI: 1.171.65; 12 
I
2
:43%,  =9 studies, cases=5,507) comparing high (midpoint: 17.4 kg) versus stable weight gain 13 
during adulthood and with each 5 kg weight gain the odds increased by 7% (2%11%; I
2
:65%, 14 
=7 studies). Although there was indication of nonlinearity (	
 <0.001) there was an 15 
increased odds of colorectal adenoma throughout the whole range of weight gain. Three studies 16 
were identified investigating the association between weight gain and colorectal adenoma 17 
recurrence and data were limited to draw firm conclusions.  18 
 Even a small amount of adult weight gain was related to a higher odds of 19 
colorectal adenoma occurrence. Our findings add to the benefits of weight control in adulthood 20 
regarding colorectal adenomas occurrence, which might be relevant for early prevention of 21 
colorectal cancer.     22 
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	 Body weight gain, body weight change, colorectal adenomas, polyps, metaanalysis, 1 
observational studies 2 
 3 
 4 
	This is the first systematic review and metaanalysis summarizing evidence on 5 
adult body weight gain and colorectal adenomas. Per 5 kg body weight gain the odds of adenoma 6 
occurrence increased by 7% (2%11%). These findings show the benefits of weight control from 7 
early adulthood regarding the occurrence of colorectal adenomas, which might be relevant for 8 
early colorectal cancer prevention.9 
 10 
 11 
 12 
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 1 
In 2012, colorectal cancer was the third most common cancer in men and the second in 2 
women, and about 694,000 deaths from colorectal cancer were documented worldwide.[1] Many 3 
modifiable lifestyle factors, including smoking, dietary factors, physical activity as well as 4 
obesity and weight gain during adulthood have been identified as influencing factors for risk of 5 
colorectal cancer.[2, 3] There is consent that adenomas –noncancerous tumors– in the colon or 6 
rectum are precursors to development of colorectal cancer, known as the adenomatocarcinoma 7 
sequence.[4, 5] Regarding this aspect, it is likely that the same risk factors as for colorectal 8 
cancer are involved in the etiology of colorectal adenomas. A growing body of evidence suggest 9 
that smoking,[6] physical activity,[7] dietary intake of fiber,[8] meat,[9] and alcohol,[10] are also 10 
associated with risk of colorectal adenomas, and serrated adenomas,[11] a subtype with strong 11 
malignant potential.[12] In addition, body fatness –both general and abdominal– has been linked 12 
to increased risk of colorectal adenomas.[1316] A recent metaanalysis indicated that the 13 
visceral adipose tissue, related to metabolic adverse effects is associated with advanced 14 
colorectal adenomas and might be a mediator for the association between obesity and colorectal 15 
adenomas.[17] Moreover, adult weight gain, a marker of body fat mass fluctuation, is related to 16 
metabolic alterations as well, even within the normal body weight range and already during early 17 
adulthood.[18] [19]  In this context, beyond body fatness, epidemiological studies have 18 
investigated whether adult weight gain is related to the occurrence and recurrence of colorectal 19 
adenomas. Even though most studies indicated a positive association between adult weight gain 20 
and risk of colorectal adenomas, some of these findings still allowed for the possibility of no 21 
increase in risk and uncertainty remains in the exact magnitude of any association.[2029]. So 22 
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far, no systematic review or metaanalysis has been conducted that summarize findings on this 1 
association. 2 
Thus, to quantify this association we conducted a metaanalysis of epidemiological 3 
studies (including crosssectional, casecontrol and prospective studies) on adult weight gain and 4 
colorectal adenomas and recurrence. In addition, we explored linear and nonlinear dose5 
response relations on adult weight change and the occurrence of colorectal adenomas. And 6 
finally, we investigated if study design, sex, adenoma location (colon vs. rectum), time period of 7 
weight assessment (weight gain in early adulthood vs during middle age), and adjustment for 8 
general body fatness might influence the association between adult weight gain and colorectal 9 
adenoma occurrence.  10 
11 
12 
This report was conducted according to standard criteria provided by the Metaanalysis Of 13 
Observational Studies in Epidemiology (MOOSE) group.[30] 14 

	
	
15 
The literature search has been conducted as part of the World Cancer Research Fund 16 
International Continuous Update Project/ American Institute for Cancer Research Continuous 17 
Update Project following a predefined protocol 18 
(http://www.wcrf.org/sites/default/files/protocol_colorectal_cancer.pdf). Relevant studies on 19 
weight gain during adulthood and colorectal adenomas were identified by searching PubMed up 20 
to December 2015. Initially (up to December 2005), several other databases were used, including 21 
Embase, CAB Abstracts, ISI Web of Science, BIOSIS, LILACS, Cochrane library, CINAHL, 22 
AMED, National Research Register and In Process Medline. As all the relevant studies were 23 
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identified using PubMed, a change in the protocol was made and only PubMed was used for the 1 
updated searches. The literature search included two outcomes, colorectal cancer and colorectal 2 
adenomas. As this systematic review and metaanalysis focus on colorectal adenomas only, we 3 
excluded studies on colorectal cancer. We conducted an update of the literature search in 4 
Medline (PubMed) for articles on adult weight change and colorectal adenomas until September 5 
2016.  6 
7 
8 
Studies were selected if they 1) reported on the association between adult weight change 9 
and adenoma occurrence or recurrence, 2) used a cohort, nested casecontrol, casecohort, case10 
control, crosssectional design, or followup studies of randomized clinical trials, and 3) 11 
provided effect estimates for this association (including hazard ratio or odds ratio (OR)) with the 12 
95% confidence interval (95% CIs). For simplicity, we use the term OR for all these estimates in 13 
the present manuscript. In addition, we defined studies as prospective if a followup period 14 
between second weight assessment and diagnosis of colorectal adenomas was available and as 15 
retrospective if the second weight measure was taken at time of colorectal adenoma assessment 16 
or recalled 1 year before. We focused on two different outcomes: adenoma occurrence (no 17 
previous adenoma was known) and adenoma recurrence (prior adenoma was diagnosed). Studies 18 
not published as original articles were excluded. Furthermore, we excluded one study reporting 19 
on changes of BMI instead of weight change because a conversion into weight change was not 20 
possible.[31]  21 
22 
		
	23 
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The following information was extracted from each study: last name of the first author, 1 
publication year, country of origin, underlying study source, duration of followup (if 2 
applicable), sex, age (range or mean), outcome (occurrence or recurrence), outcome assessment, 3 
sample size, number of cases, number of controls (if applicable), assessment of weight change 4 
and age at weight assessment, quantity of weight change, most fully adjusted estimates and 5 
corresponding 95% CIs, and variables adjusted for in the statistical analysis. Data for men and 6 
women, or colon and rectal adenomas, were extracted separately, if information was provided by 7 
the single studies.   8 
 9 
				10 
The associations between weight gain during adulthood and colorectal adenoma 11 
occurrence or recurrence were analyzed by comparing extreme categories of weight gain during 12 
adulthood (high weight gain vs. low weight gain), and summary ORs (95% CI) were calculated 13 
by applying random effects models. Two studies reported on adult weight gain in pounds,[24, 14 
26] and quantifications were converted in kg (1 kg ≅ 2.2 lbs). For one study, we converted adult 15 
weight change in kg/year into weight change per kg by multiplying the quantification with the 16 
time interval between both weight assessments.[28] If stable weight was not used as reference 17 
category in single studies,[21, 23] we used the method of Hamling 	. to convert risk estimates 18 
to being relative to this reference category.[32] For studies that reported estimates stratified by 19 
sex,[22] or adenoma site (colon, rectal and both),[29] a fixed effect model was used to combine 20 
the estimates for the main analysis.  21 
Heterogeneity between studies was investigated by using the I
2
 test and to investigate 22 
potential influencing factors for the association between adult weight gain and colorectal 23 
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adenoma occurrence, we performed subgroup and metaregression analyses.[33] We stratified 1 
our analysis by: study design (prospective vs. retrospective), sex (men vs. women), site of 2 
adenoma (colon vs. rectum), time of weight assessment (early vs. midlife adulthood), definition 3 
of high weight gain category (≥10 vs <10 kg), used reference category (weight loss included vs. 4 
stable weight), outcome assessment (colonoscopy vs. sigmoidoscopy vs. selfrepots), geographic 5 
area (Asia vs. Europe vs. USA), indication (without indication vs. with indication), and 6 
adjustment (yes vs. no) for baseline weight/body mass index/waist circumference, physical 7 
activity, smoking, alcohol intake, and family history of colorectal cancer. Stratified analyses for 8 
adenoma recurrence were not conducted because of the restricted number of studies.  9 
Furthermore, we performed a linear doseresponse metaanalysis of the association 10 
between adult weight gain per 5 kg and colorectal adenoma occurrence. Studyspecific slopes 11 
(linear trends) and 95% CIs from the natural logarithm of the ORs across categories of weight 12 
change were calculated by using the method described by Greenland and Longnecker and 13 
implemented by Orsini.[34, 35] This method requires the distribution of cases, personyears/non14 
cases, the quantification of the exposure and the risk estimates with corresponding 95% CIs for 15 
at least three weight change categories. The distribution of cases, person years or noncases was 16 
estimated if the information was missing. The midpoint between the lower and upper limit for 17 
each exposure category was calculated, if studies reported ranges and mean values were not 18 
reported. When the lowest or highest category was openended, we expected that the range was 19 
similar to the adjacent category. Some of the studies included weight loss in the reference 20 
category, and we excluded these studies in a sensitivity analysis.[20, 25, 27] In another 21 
sensitivity analysis, we repeated the doeresponse metaanalysis stratified by study design. In 22 
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addition, we investigated adult weight gain per kg/year to consider different time periods 1 
between the both weight assessments.  2 
Moreover, a potential nonlinear relation between weight change during adulthood and 3 
colorectal adenoma occurrence was investigated by performing cubic spline regression models 4 
and indication of nonlinearity was tested by using likelihood ratio test.[36]  We included all 5 
categories of weight change (even the weight loss categories) to get an idea about the whole 6 
relation between weight change and occurrence of colorectal adenoma. We repeated the non7 
linear doseresponse metaanalysis only including prospective studies. For adenoma recurrence 8 
the number of studies was restricted and we were not able to investigate the doseresponse 9 
relation.  10 
Small study effects such as publication bias were assessed by visual inspection of the 11 
funnel plot for asymmetry and by applying Egger’s test.[37]  12 
All statistical analyses were performed using STATA version 13.1 software (StataCorp, 13 
College Station, TX).  14 
 15 
16 
The flow chart of the literature search is shown in !". In total, we included 10 17 
studies (6 retrospective and 4 prospective studies)[2029] on adult weight change and colorectal 18 
adenomas in our metaanalysis, with 9 studies focusing on occurrence[2023, 2529] and 3 19 
studies on recurrence.[2224] The characteristics of included studies are shown in ".  20 
 21 
	

22 
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 The association between weight gain during adulthood and colorectal adenoma 1 
occurrence was investigated in 9 studies (5 retrospective and 4 prospective studies),[2023, 252 
29] including 5,507 cases among 59,187 participants. Out of these, weight gain was assessed 3 
during early adulthood in 6 and during midlife in 3 studies.   4 
In the metaanalysis comparing high (midpoint 17.4 kg) versus low weight gain during 5 
adulthood, the summary OR for colorectal adenoma occurrence was 1.39 (95% CI: 1.171.65) 6 
with moderate heterogeneity (I
2
: 43%, 
=0.08) (!#).  7 
Subgroup analyses are shown in #. The findings stratified by sex suggested that the 8 
association was stronger in women [summary OR (95% CI) 1.36 (1.011.83);  =4 studies] 9 
compared to men [summary OR (95% CI) 1.05 (0.711.55);  =3 studies], but differences were 10 
not statistically significant ( for heterogeneity by sex=0.51). When we restricted the stratified 11 
analysis by sex to studies providing both information (for men and women separately,  = 2 12 
studies), the summary OR for women was 0.78 (95% CI: 0.311.95) and for men 1.15 (95% CI: 13 
0.462.86), with no indication for interaction ( for heterogeneity by sex=0.68). Stronger 14 
associations were observed for studies which defined high adult weight gain as greater or equal 15 
than 10 kg [summary OR (95% CI) 1.55 (1.261.90)] compared to studies investigating less than 16 
10 kg [summary OR (95% CI) 1.24 (0.951.63)]; but differences were not statically significant 17 
( for heterogeneity by weight gain category=0.21). We did not observe a difference of the 18 
association after stratification by study design (prospective vs. retrospective studies) (# 19 
and $

	$") and adjustment for excess body weight (#). 20 
In other subgroup analyses (stratification by site of adenoma, time of weight assessment, 21 
geographic area, indication and study quality criteria, such as definition of reference category, 22 
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outcome assessment, adjustment for confounders) the findings remained robust and no 1 
statistically significant differences were observed.  2 
For the doseresponse metaanalysis we included 7 studies.[20, 21, 23, 25, 2729] Per 3 
each 5 kg weight gain during adulthood the odds of colorectal adenoma was increased by 7% 4 
(95% CI: 2%11%) (!%). There was moderate to high heterogeneity (I
2
: 65%, 5 

=0.009), In a sensitivity analysis, excluding studies using a combination of adult 6 
weight gain and weight loss in the reference category,[23, 28, 29, 38] the odds of colorectal 7 
adenoma was slightly higher [summary OR (95% CI) per 5 kg weight gain during adulthood: 8 
1.08 (1.031.12),  =4 studies)] and there was no indication for heterogeneity between the 9 
studies (I
2
: 0%, 
=0.87). No differences by study design (prospective vs retrospective) 10 
was observed ($

	$#)The nonlinear doseresponse curve indicated 11 
evidence of nonlinearity (	
<0.001), but no threshold of adult weight gain in relation to 12 
risk increase was observed. The curve shows an increase odds of colorectal adenoma throughout 13 
all the range of adult weight gain investigated, although the curve was steeper at lower levels of 14 
weight gain than at higher levels (!&). After restricting our nonlinear doseresponse meta15 
analysis to prospective studies only, findings did not change substantially ($

	16 
$%) When we considered the time interval of weight gain during adulthood, the odds of 17 
colorectal adenoma was 30 % increased by each kg adult weight gain per year [summary OR 18 
(95% CI) for 1 kg/y: 1.30 (1.101.55); I
2
: 70%, 
=0.003].  19 
There was no indication for publication bias (Egger’s test: =0.57; $

	20 
$&' 21 
 22 
	

23 
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For the analysis on weight gain during adulthood and adenoma recurrence we included 3 1 
studies (2 retrospective and 1 prospective studies),[2224] including 1,350 cases among 5,559 2 
participants. One study reported on weight gain during early adulthood and 2 on weight gain 3 
during midlife. The summary OR (95% CI) in high versus low metaanalysis was 1.14 (0.884 
1.49), without statistically significant indication of heterogeneity between studies (I
2
=48%, 5 

=0.15) (!#). We did not conduct subgroup analyses, linear and nonlinear dose6 
response metaanalysis of weight gain and adenoma recurrence because of the limited number of 7 
studies. 8 
9 
(10 
This is the first systematic review and metaanalysis reporting on the association between 11 
weight gain during adulthood and colorectal adenomas. Findings indicated that high adult weight 12 
gain was associated with higher odds of adenoma occurrence. For a 5 kg weight gain during 13 
adulthood the odds of colorectal adenoma occurrence increased by 7%. Although there was 14 
indication for a nonlinear relation, with a slightly steeper relation at lower than higher values of 15 
weight gain, the curve shows an increased odds of colorectal adenomas throughout all the range 16 
of adult weight gain investigated and a reduction in odds of adenoma occurrence with weight 17 
loss. For adenoma recurrence the number of studies was too limited to draw clear conclusions.  18 
Our findings on adult weight gain during adulthood and colorectal adenoma occurrence 19 
are comparable with findings on weight gain and risk of colorectal cancer.[3] Our findings 20 
indicated that for each 5 kg gain in weight during adulthood the odds of colorectal adenoma 21 
increased by 7% (2%11%), and the risk for colorectal cancer by 4% (2%5%).[3] In addition, 22 
these findings are in line with previous reports on anthropometric measures, including measures 23 
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of general and abdominal obesity as well as quantification of specific fat depots, showing 1 
positive associations between body fatness and colorectal adenomas.[1317, 39]  2 
We did not identify statistically significant differences in subgroups analyses, but 3 
findings need more consideration. After stratification by sex, findings indicated that the 4 
association was restricted to women and not significant in men, however, the low number of 5 
studies in these subgroup analyses is a limitation. To explore if these findings might be 6 
influenced by other characteristics of the studies, we restricted this analysis only to studies that 7 
provided findings for both, men and women separately.[22, 23] These two studies, one 8 
conducted in Korea, including participants undergoing a screening program, and the other study 9 
from the Netherlands, including participants with MMR gene mutation carrier, indicated that 10 
associations were stronger in men than in women, but differences were not statistically 11 
significant.[22, 23] The metaanalysis on weight gain during adulthood and risk of colorectal 12 
cancer provided evidence that the association was stronger in men than in women,[3] whereas 13 
findings on anthropometric measures and colorectal adenoma did not show differences between 14 
men and women.[13, 1517] However, for colorectal adenoma the number of studies accounting 15 
for men and women separately is limited and studies focusing on differences are warranted. 16 
After stratification by site, we did not observe statistically significant differences between colon 17 
and rectal adenomas with weight gain during adulthood, which is comparable to previous 18 
findings on colorectal cancer.[3] But again, number of studies were limited and further studies 19 
are needed. We stratified our analysis by studies adjusting and not adjusting for body fatness 20 
defined by weight, BMI, or waist circumference. The results did not differ appreciably between 21 
the two groups, indicating that weight gain during adulthood is associated with colorectal 22 
adenoma, independently of body fatness.  23 
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The underlying mechanism for the association between adult weight change and adenoma 1 
occurrence is not clear yet. Lifestyle intervention studies provided evidence that weight loss 2 
improved levels of oxidative stress (including CRP, oxidized lowdensity lipoprotein, fluorescent 3 
oxidation products, F2isoprostanes), metabolic biomarkers (including leptin and adiponectin) 4 
and insulin resistance,[4043] whereas observational studies indicated that body weight gain 5 
during adulthood is related with metabolic alterations.[18, 19, 44] Recently, a large European 6 
cohort study reported that individuals with normal weight but a metabolic unhealthy status 7 
(defined by hyperinsulinaemia) were at higher risk of colorectal cancer compared to metabolic 8 
healthy and normal weight individuals.[45] This study also showed that overweight individuals, 9 
but metabolically healthy were at lower risk of colorectal cancer compared to overweight 10 
individuals who were metabolic unhealthy. These findings underline the hypothesis that 11 
metabolic alterations beyond BMI might play a role in the etiology of colorectal cancer. While 12 
metabolic perturbations are associated with increased risk of colorectal cancer,[38, 4548] the 13 
evidence for colorectal adenomas is less clear,[4952] explainable by the lack of studies, 14 
particularly prospective studies.[53] Findings from casecontrol and crosssectional studies 15 
indicated that the prevalence of the metabolic syndrome and insulin resistance was higher and 16 
levels of adiponectin lower in individuals with colorectal adenoma compared to the control 17 
goup,[52, 54, 55] which might be a potential explanation for our observed association. More 18 
studies investigating the pathomechanisms of colorectal adenomas in relation with adult weight 19 
gain and body fatness in general, are needed.  20 
Our metaanalysis has several strengths. First, to our knowledge this is the first 21 
systematic review and metaanalysis summarizing the evidence between body weight gain 22 
during adulthood and colorectal adenoma. Second, this report does not focus on high versus low 23 
Annals of Oncology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
15 
 
analysis only, but linear and nonlinear doseresponse analysis were conducted to explore the 1 
strength and shape of the relation between adult weight gain and colorectal adenoma occurrence. 2 
Third, we performed stratified analysis to investigate the robustness of our findings, considering 3 
biological and methodological factors. In this context, we could show that the association 4 
persisted even after adjusting for body fatness, defined by weight, BMI, or waist circumference. 5 
On the contrary, our study has limitations that should be discussed. First our study included both, 6 
retrospective and prospective studies. However, we stratified our metaanalysis by study design 7 
and findings were comparable. In addition, most of the studies included asymptomatic 8 
individuals and only two studies were based on individuals with indications. In our stratified 9 
analyses results did not change considerably, making recall bias from casecontrol or cross10 
sectional studies less likely. Second, some of the studies included in our metaanalysis relied on 11 
colorectal adenoma detection rather than onset and it is possible that adenomas have developed 12 
earlier. If studies did not conduct a colonoscopy at baseline for cohort studies or in the past for 13 
casecontrol and crosssectional studies, prevalent colorectal adenomas are likely included, 14 
which might have an influence on the temporal sequence of the relation between adult weight 15 
change and colorectal adenoma occurrence. However, as discussed earlier colorectal adenomas 16 
mostly do not show any symptoms and it is unlikely that participants changed their weight 17 
intentionally. In addition, a previous metaanalysis showed that unintentional weight loss was 18 
less than 10% for individuals diagnosed with colorectal adenomas.[56] Third, measurement error 19 
of adult weight gain cannot be ruled out. For early weight gain information was based on 20 
recalled weight, which might be a valid measurement,[57, 58] but tended to be underreported 21 
depending on the current weight and amount of weight gain.[59] If body weight was 22 
underestimated in the studies included in our metaanalysis, estimates would be biased toward 23 
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the null. Fourth, the analysis on adenoma recurrence and subgroup analyses by sex and adenoma 1 
site were restricted by the small number of studies providing the information separately. These 2 
findings should be interpreted with caution and more studies investigating sex and sitespecific 3 
associations between adult weight gain and colorectal adenoma occurrence and recurrence are 4 
warranted.  5 
 In conclusion, this metaanalysis indicated evidence that weight change during adulthood 6 
is associated with colorectal adenoma occurrence independently of excess body weight. In the 7 
nonlinear doseresponse metaanalysis, colorectal adenomas were less common in individuals 8 
reporting weight loss and more common in individuals with weight gain. Even a small amount of 9 
adult weight gain was related to higher odds of colorectal adenoma. Our findings show the 10 
benefits of weight control from early adulthood regarding the occurrence of colorectal adenomas 11 
– a known precursor of colorectal cancer – which might be relevant for early prevention.  12 
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Figure 1: Flow chart of study selection  2 
Figure 2: High vs low metaanalysis for weight gain and colorectal adenoma occurrence and 3 
recurrence 4 
Figure 3: Doseresponse metaanalysis for weight gain per 5 kg and colorectal adenoma 5 
occurrence 6 
Figure 4: Nonlinear doseresponse metaanalysis for weight gain and colorectal adenoma 7 
occurrence (	
 <0.001) 8 
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Lubin 1997 
(Israel)[25] 
Screening Program of 
the gastroenterology 
Department at the Tel 
Aviv Medical Center,  
Retrospective study 
M & F, 
21,75 y 
colorectal 
adenomas, 
colonoscopy 
cases: 196 
controls: 196 
self,reported 
baseline weight 
and recalled 
weight at age 18  
<4 kg (ref),  
4,11 kg,  
>11 kg 
<4: 1  
411: 1.5 (1.1,2.1)  
 >11: 2.2 (1.2,4.1) 
total energy and 
physical activity  
Bird, 1997         
(US)[20]  
Screening at Southern 
California Kaiser 
Permanente medical 
centers,  
Retrospective study 
M & F, 
50,75 y 
colorectal 
adenomas,  
sigmoidoscopy 
cases: 483   
controls: 483 
self,reported 
baseline weight 
and recalled 
weight at age 18  
Quartiles: 
Q1:,34.1,4.5 kg (ref)  
Q2:>4.5,13.6 kg 
Q3:>13.6,22.7 kg 
Q4:>22.7,81.8 kg 
Q1: 1  
Q2: 1.0 (0.7,1.5)  
Q3: 1.1 (0.7,1.7)  
Q4: 1.1 (0.7,1.8)  
sex, age, date 
sigmoidoscopy, 
center, BMI  
Kono, 1999 
(Japan)[21] 
Health examination at 
the Japan Self 
Defence Forces,  
Retrospective study 
M, 
47,55 y 
colon 
adenomas,  
colonoscopy 
cases: 189 
controls: 226 
measured 
baseline weight 
and recorded 
weight 10 y 
before  
≤ ,2 kg  (ref) 
,1,1kg 
2,5 kg  
≥ 6kg 
≤ 2: 1  
11: 1.6 (0.9,2.7)  
25: 1.8 (1.0,3.0)  
≥ 6: 2.2 (1.0,4.8) 
hospital, rank in the 
self,defence force, 
smoking, alcohol 
use 
Wernli, 2010      
(US)[29] 
Group Health,  
Retrospective study 
M & F,     
20,74 y 
colorectal 
adenomas,  
colonoscopy 
colon: 519 
rectum: 691 
both: 227 
controls: 772 
self,reported 
recalled weight 
1y before 
colonoscopy and 
at age 18 y 
weight loss 
0,5 kg 
6,10 kg 
11,20 kg 
>21 kg 
Colon:  
weight loss: 1.03 (0.60,
1.78) 
05 kg: 1 
610 kg: 1.23 (0.83,1.82) 
 1120 kg: 1.18 (0.84,
1.66) 
>21 kg: 1.41 (0.99,2.02) 
Rectum:  
weight loss: 1.26 (0.78,
2.03) 
0,5 kg: 1 
6,10 kg: 1.37 (0.96,1.96)   
11,20 kg: 1.28 (0.94,1.75)  
>21 kg: 1.29 (0.93,1.80)  
Both lesions:  
weight loss: 1.22 (0.54,
2.74)                 
0,5 kg: 1  
6,10 kg: 1.34 (0.74,2.44) 
11,20 kg: 1.90 (1.15,3.14)  
age, sex, race, 
education, smoking 
status, alcohol 
intake, NSAID use, 
family history of 
CRC, menopausal 
status, hormone 
use  
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>21 kg: 2.16 (1.28,3.63) 
Laiyemo, 2012  
(US)[24] 
Polyp Prevention Trial,   
Retrospective study, 
4 y 
M & F, 
61.0 y  
colorectal 
adenoma 
recurrence,  
colonoscopy 
: 1,826  
Recurrence: 
723 
measured weight 
at baseline and 
after 4 y (at 
diagnosis of 
recurrence) 
loss ≥ 10 ibs  
loss (5,9 ibs)  
no change (ref) 5,9 ibs  
≥10 ibs 
≤10 ibs: 0.91 (0.77,1.07)  
,5, ,9 ibs) 0.90 (0.76,1.07) 
no change: 1 (ref) 
5,9 ibs: 0.97 (0.82,1.16) 
≥10 ibs: 1.03 (0.87,1.23) 
age, sex, NSAID 
use, smoking 
status, baseline 
weight, dietary 
randomized 
assignment, family 
history of CRC 
Jung, 2016 
(Korea)[23] 
Health screening 
program at Kangbuk 
Samsung Hospital, 
Retrospective study, 
2.2 y 
M & F, 
41.2 y 
colorectal 
adenomas and  
recurrence, 
colonoscopy 
: 3,121 
without and 
2,176 with 
adenoma 
Cases: 447 
Recurrence: 
591 
measured weight 
at baseline and 
after 2.2 y (at 
diagnosis of 
adenoma or 
recurrence) 
Quartiles:  
Q1:<,1.6 kg (ref) 
Q2,1.6,0.1 kg 
Q3:0.2,1.8 kg 
Q4:≥ 1.9 kg 
Adenomas: 
All: 
Q1: 1  
Q2: 1.24 (0.95,1.63)  
Q3: 1.28 (0.98,1.66)  
Q4: 1.17 (0.89,1.53) 
Men: 
Q1: 1  
Q2: 1.31 (0.98,1.74)  
Q3: 1.31 (0.98,1.74)  
Q4: 1.25 (0.94,1.67) 
Women: 
Q1: 1  
Q2: 0.84 (0.38,1.88)  
Q3: 1.11 (0.53,2.31)  
Q4: 0.62 (0.25,1.51) 
 
Recurrence: 
All: 
Q1: 1  
Q2: 1.17 (0.93,1.47)  
Q3: 1.25 (0.98,1.58)  
Q4: 1.29 (1.02,1.64) 
Men: 
Q1: 1  
Q2: 1.15 (0.91,1.46)  
Q3: 1.28 (1.00,1.64)  
Q4: 1.31 (1.03,1.67) 
Women: 
Q1: 1  
Q2: 1.23 (0.51,2.99)  
Q3: 1.20 (0.46,3.17)  
Q4: 1.23 (0.45,3.36)  
Age, sex, smoking 
status, family 
history of CRC, 
NSAID use, 
baseline weight 
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Sedjo, 2007       
(US)[26] 
Insulin Resistance 
Atherosclerosis Study, 
Prospective study, 
~5y 
M & F, 
mean 
age 64 y 
colorectal 
adenomas,  
colonoscopy 
 
: 600               
cases: 136  
measured 
baseline weight 
and prospective 
weight after 5 y 
≤ ,4 pounds 
 ,4,4 pounds (ref)  
>4 pounds 
≤4: 1.52 (0.60,3.87) 
44: 1  
>4: 2.17 (1.15,4.11) 
age, sex, clinic, 
ethnicity, smoking, 
estimated energy 
expenditure, 
previous polyp 
history, baseline 
BMI 
Wise, 2008  
(US)[27] 
Black Women’s Health 
Study  
Prospective study, 
6.3 y 
F,  
mean 
43.5 y 
colorectal 
adenomas ,  
self,reported 
: 33,403 
Cases: 1,189 
self,reported 
baseline weight 
and recalled 
weight at age 18 
<5 kg (ref),  
5,14 kg 
15,29 kg 
≥30 kg 
<5 kg: 1 
5,14 kg: 1.44 (1.09,1.91) 
15,29 kg: 1.57 (1.20,2.06) 
≥30 kg: 1.76 (1.33,2.33) 
Age, questionnaire 
cycle, physical 
activity, family 
history of colorectal 
cancer, smoking, 
education, 
nonsteroidal anti,
inflammatory drug 
use, menopausal 
status, postmeno,
pausal hormone 
use, red meat 
intake, fiber intake, 
energy, BMI at age 
18 
Botma, 2010      
(The 
Netherlands)[2
2] 
GEOLynch study 
(MMR gene mutation 
carrier), 
Prospective study, 
1.7 y 
M & F, 
44.2 y 
colorectal 
adenomas and 
recurrence, 
colonoscopy 
: 243 
Cases: 22 
Recurrence: 
36 
self,reported 
baseline weight 
and recalled 
weight at age 18 
(for occurrence), 
and after 2 y (for  
recurrence )  
For  occurrence: 
grouped by median 
(not specified),    
for recurrence: 
± 2 kg 
>2 kg  
Adenomas: 
Men: 
low 
3.60 (0.38,34.28)   
Women:  
0.83 (0.20,3.48)  
Recurrence: 
Men: 
± 2 kg: 1 
>2 kg: 1.73 (0.67,4.45) 
Women: 
± 2 kg: 1 
>2 kg: 4.09 (1.04,16.19) 
age, sex, smoking 
status, alcohol 
intake  
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Morois, 2010 
(France)[28] 
E3N,EPIC,study –
France, 
Prospective study, 
2 y  
F,  
mean 
53.1 y 
 
Colon and 
rectum 
adenomas,  
colonoscopy 
: 17,391 
cases: 1,408 
self,reported 
weight at 
baseline and self,
reported 
prospective 
weight every 2 y 
<0 kg/year 
0 (ref) kg/year 
0.1,0.49 kg/year 
≥ 0.5 kg/year 
<0: 1.12 (0.92,1.35)  
0 (ref)  
0.1,0.49: 1.25 (1.05,1.49) 
≥ 0.5: 1.23 (1.03,1.46) 
energy intake, 
alcohol intake, total 
physical activity, 
smoking status, 
CRC in first degree 
relatives, 
educational level, 
menopausal status, 
use of menopausal 
hormone therapy 
BMI, body mass index; CRC, colorectal cancer, F, female; M, male; NSAID, non,steroidal anti,inflammatory drugs; , number; Y, year 
Annals of Oncology
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Table 2. Summary odds ratio (OR) and 95% confidence intervals (95% CI) of high versus low meta#
analyses of weight gain and occurrence of colorectal adenomas by subgroups  
 	


 

	 	





 1.39 (1.17#1.65) 9 43 0.08  
    
0.78  Prospective 1.37 (1.05#1.80) 5 61 0.04 
 Retrospective  1.45 (1.19#1.76) 4 3 0.38 
    
0.51  Men  1.05 (0.71#1.55) 3 0 0.43 
 Women  1.36 (1.01#1.83) 4 49 0.12 
     
0.73  Colon 1.27 (1.07#1.51) 3 0 0.80 
 Rectum  1.20 (0.93#1.55) 2 0 0.49 
    
0.93  Early adulthood 1.40 (1.10#1.77) 6 51 0.07 
 Mid#life adulthood 1.40 (1.00#1.95) 3  30 0.24 
 !    
0.21  <10 kg 1.24 (0.95#1.63) 4 42 0.16 
 ≥ 10 kg 1.55 (1.26#1.90) 4 31 0.05 
"#!     
0.61 
 Asia 1.36 (0.76#2.45) 3 64 0.06 
 Europe 1.23 (1.04#1.46) 2 0 0.97 
 USA 1.54 (1.26#1.89) 4 28 0.25 
!!     
0.32  Weight loss included 1.59 (1.19#2.12) 4 26 0.26 
 Stable weight  1.30 (1.07#1.58) 5 42 0.14 
$!     
0.47 
 Colonoscopy 1.36 (1.12#1.65) 7 38 0.14 
 Sigmoidoscopy 1.10 (0.69#1.76) 1 # # 
 Self#reported 1.76 (1.33#2.33) 1 # # 
!     
0.92  Without indication  1.40 (1.11#1.76) 7 56 0.04 
 With indication  1.45 (1.17#1.81) 2 0 0.81 
%&'(&!!!    
0.59  Yes 1.33 (1.06#1.67) 6 54 0.06 
 No 1.47 (1.23#1.76) 3 0 0.96 
%#!!)    
0.25  Yes 1.51 (1.20#1.90) 4 55 0.08 
 No 1.25 (1.02#1.52) 5 10 0.35 
%*     
0.85  Yes 1.38 (1.15#1.66) 7 45 0.09 
 No 1.35 (1.01#1.80) 2 11 0.29 
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!*    
0.78  Yes 1.31 (1.15#1.50) 4 0 0.70 
 No 1.40 (1.06#1.85) 5 60 0.04 
%!!!!    
0.68  Yes 1.34 (1.08#1.65) 4 65 0.03 
 No 1.44 (1.14#1.82) 5 0 0.57 
a 
,  for heterogeneity within each subgroup 
b 
,  for heterogeneity between subgroups with meta#regression
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